LTS:0QB4 (Germany)
Â
Akt. nach Kapitalherabsetzung
€
11.3
(0%)
Apr 15
What is a stock summary page? Click here for an overview.
Business Description
Medios AG
NAICS : 515120
ISIN : DE000A1MMCC8
Share Class Description:
LTS:0QB4: Akt. nach KapitalherabsetzungCompare
Compare
Traded in other countries / regions
ILM1.Germany0QB4.UKILM1.AustriaMEDOF.USA IPO Date
2012-11-22Description
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.45 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.47 | |||||
| Debt-to-EBITDA | 3.72 | |||||
| Interest Coverage | 2.81 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.86 | |||||
| Beneish M-Score | -3.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.1 | |||||
| 3-Year EBITDA Growth Rate | 13.4 | |||||
| 3-Year EPS without NRI Growth Rate | 14.6 | |||||
| 3-Year FCF Growth Rate | 3 | |||||
| 3-Year Book Growth Rate | 5.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 44.14 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 3.79 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.01 | |||||
| 9-Day RSI | 44.48 | |||||
| 14-Day RSI | 42.88 | |||||
| 3-1 Month Momentum % | 5.41 | |||||
| 6-1 Month Momentum % | -11.55 | |||||
| 12-1 Month Momentum % | -66.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.02 | |||||
| Quick Ratio | 1.49 | |||||
| Cash Ratio | 0.62 | |||||
| Days Inventory | 15.99 | |||||
| Days Sales Outstanding | 25.84 | |||||
| Days Payable | 17.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.7 | |||||
| Shareholder Yield % | -80.01 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 8.04 | |||||
| Operating Margin % | 1.62 | |||||
| Net Margin % | 0.67 | |||||
| FCF Margin % | 3.58 | |||||
| ROE % | 2.55 | |||||
| ROA % | 1.57 | |||||
| ROIC % | 2.75 | |||||
| 3-Year ROIIC % | 2.49 | |||||
| ROC (Joel Greenblatt) % | 28.22 | |||||
| ROCE % | 5.53 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.63 | |||||
| Forward PE Ratio | 7.29 | |||||
| PE Ratio without NRI | 21.63 | |||||
| Shiller PE Ratio | 17.26 | |||||
| Price-to-Owner-Earnings | 4.7 | |||||
| PEG Ratio | 0.93 | |||||
| PS Ratio | 0.15 | |||||
| PB Ratio | 0.55 | |||||
| Price-to-Tangible-Book | 1130 | |||||
| Price-to-Free-Cash-Flow | 4.34 | |||||
| Price-to-Operating-Cash-Flow | 3.96 | |||||
| EV-to-EBIT | 13.06 | |||||
| EV-to-EBITDA | 6.68 | |||||
| EV-to-Forward-EBITDA | 4.01 | |||||
| EV-to-Revenue | 0.23 | |||||
| EV-to-Forward-Revenue | 0.2 | |||||
| EV-to-FCF | 6.07 | |||||
| Price-to-Projected-FCF | 0.55 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.87 | |||||
| Price-to-Graham-Number | 29.74 | |||||
| Earnings Yield (Greenblatt) % | 7.66 | |||||
| FCF Yield % | 22.84 | |||||
| Forward Rate of Return (Yacktman) % | 27.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medios AG Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,883.038 | ||
| EPS (TTM) (€) | 0.51 | ||
| Beta | -0.51 | ||
| 3-Year Sharpe Ratio | -0.7 | ||
| 3-Year Sortino Ratio | -0.72 | ||
| Volatility % | 68 | ||
| 14-Day RSI | 42.88 | ||
| 14-Day ATR (€) | 0.320826 | ||
| 20-Day SMA (€) | 11.829 | ||
| 12-1 Month Momentum % | -66.36 | ||
| 52-Week Range (€) | 10.2 - 38.22378 | ||
| Shares Outstanding (Mil) | 25.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medios AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medios AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medios AG Frequently Asked Questions
What is Medios AG(LTS:0QB4)'s stock price today?
The current price of LTS:0QB4 is €11.30. The 52 week high of LTS:0QB4 is €38.22 and 52 week low is €10.20.
When is next earnings date of Medios AG(LTS:0QB4)?
The next earnings date of Medios AG(LTS:0QB4) is .
Does Medios AG(LTS:0QB4) pay dividends? If so, how much?
Medios AG(LTS:0QB4) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers